|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.26 EUR | +2.13% |
|
+0.27% | +3.63% |
| 04-20 | LANXESS AG : Barclays reaffirms its Sell rating | ZD |
| 04-20 | Barclays raises Lanxess target to 14 euros - "Underweight" | DP |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.13 | 2.16 | -0.48 | 0.15 | -0.96 | |||||
Return on Total Capital | 4.64 | 2.96 | -0.63 | 0.19 | -1.23 | |||||
Return On Equity % | 6.48 | 4.52 | -18.85 | -3.87 | -14.24 | |||||
Return on Common Equity | 6.48 | 4.5 | -18.9 | -3.9 | -14.28 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.41 | 23.95 | 18.89 | 20.39 | 19.94 | |||||
SG&A Margin | 16.77 | 17.28 | 18.44 | 18.49 | 19.23 | |||||
EBITDA Margin % | 12.36 | 10.57 | 6.26 | 8.18 | 5.85 | |||||
EBITA Margin % | 7.91 | 6.59 | 1.3 | 2.91 | 0.25 | |||||
EBIT Margin % | 6.43 | 4.66 | -1.21 | 0.36 | -2.36 | |||||
Income From Continuing Operations Margin % | 2.9 | 2.29 | -12.54 | -2.76 | -10.15 | |||||
Net Income Margin % | 3.53 | 3.09 | 6.6 | -2.78 | -10.17 | |||||
Net Avail. For Common Margin % | 2.9 | 2.27 | -12.56 | -2.78 | -10.17 | |||||
Normalized Net Income Margin | 3.73 | 2.84 | -3.12 | -1.16 | -2.93 | |||||
Levered Free Cash Flow Margin | -2.1 | -13.44 | 25.05 | -1.71 | 9.96 | |||||
Unlevered Free Cash Flow Margin | -1.54 | -12.86 | 25.7 | -1.25 | 10.44 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.78 | 0.74 | 0.64 | 0.66 | 0.65 | |||||
Fixed Assets Turnover | 3.19 | 3.3 | 2.92 | 2.88 | 2.86 | |||||
Receivables Turnover (Average Receivables) | 7.7 | 7.46 | 7.48 | 7.76 | 7.38 | |||||
Inventory Turnover (Average Inventory) | 4.23 | 3.52 | 3.38 | 3.74 | 3.54 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.84 | 2 | 2.48 | 1.95 | 1.67 | |||||
Quick Ratio | 1.14 | 0.68 | 1.29 | 0.94 | 0.87 | |||||
Operating Cash Flow to Current Liabilities | 0.17 | 0.07 | 0.71 | 0.29 | 0.19 | |||||
Days Sales Outstanding (Average Receivables) | 47.41 | 48.94 | 48.82 | 47.14 | 49.45 | |||||
Days Outstanding Inventory (Average Inventory) | 86.36 | 103.67 | 107.94 | 97.78 | 103.22 | |||||
Average Days Payable Outstanding | 49.12 | 49.12 | 47.72 | 44.59 | 49.15 | |||||
Cash Conversion Cycle (Average Days) | 84.65 | 103.49 | 109.04 | 100.34 | 103.52 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 93.14 | 95.93 | 66.78 | 65.59 | 72.37 | |||||
Total Debt / Total Capital | 48.22 | 48.96 | 40.04 | 39.61 | 41.99 | |||||
LT Debt/Equity | 75.2 | 77.19 | 65.19 | 52.87 | 54.43 | |||||
Long-Term Debt / Total Capital | 38.93 | 39.39 | 39.08 | 31.93 | 31.58 | |||||
Total Liabilities / Total Assets | 64.23 | 60.76 | 53.37 | 52.71 | 54.83 | |||||
EBIT / Interest Expense | 7.25 | 5.03 | -1.16 | 0.49 | -3.05 | |||||
EBITDA / Interest Expense | 14.75 | 12.17 | 6.87 | 12.4 | 8.93 | |||||
(EBITDA - Capex) / Interest Expense | 7.6 | 6.75 | 2.21 | 5.6 | 1.68 | |||||
Total Debt / EBITDA | 3.55 | 4.65 | 6.26 | 5.17 | 6.45 | |||||
Net Debt / EBITDA | 2.3 | 4.21 | 5.23 | 4.11 | 5.18 | |||||
Total Debt / (EBITDA - Capex) | 6.88 | 8.39 | 19.42 | 11.45 | 34.23 | |||||
Net Debt / (EBITDA - Capex) | 4.46 | 7.6 | 16.22 | 9.11 | 27.51 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 23.8 | 32.57 | -16.99 | -5.18 | -10.89 | |||||
Gross Profit, 1 Yr. Growth % | 18.57 | 27.02 | -34.54 | 2.37 | -12.87 | |||||
EBITDA, 1 Yr. Growth % | 17.93 | 15.54 | -50.7 | 24.05 | -36.28 | |||||
EBITA, 1 Yr. Growth % | 27.51 | 17.14 | -83.58 | 112.64 | -92.43 | |||||
EBIT, 1 Yr. Growth % | 27.89 | 9.28 | -121.66 | -128.4 | -682.61 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -75.91 | 59.48 | -555.14 | -79.1 | 227.27 | |||||
Net Income, 1 Yr. Growth % | -69.83 | -6.37 | 77.2 | -139.95 | 225.99 | |||||
Normalized Net Income, 1 Yr. Growth % | -62.09 | 17.76 | -192.1 | -64.66 | 123.95 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -75.38 | 58.62 | -558.15 | -79 | 225.99 | |||||
Accounts Receivable, 1 Yr. Growth % | 44.15 | -12.86 | -22.35 | 8.92 | -20.23 | |||||
Inventory, 1 Yr. Growth % | 52.62 | 13.96 | -26.92 | -0.88 | -9.42 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 19.2 | -10.3 | -1.38 | -6.3 | -14.44 | |||||
Total Assets, 1 Yr. Growth % | 18.45 | 7.15 | -14.37 | 0.48 | -20.21 | |||||
Tangible Book Value, 1 Yr. Growth % | -8.37 | -12.42 | 58.98 | 15.03 | -31.42 | |||||
Common Equity, 1 Yr. Growth % | 25.16 | 17.7 | 1.81 | 1.89 | -23.79 | |||||
Cash From Operations, 1 Yr. Growth % | -30.43 | -60.93 | 427.04 | -39.38 | -43.11 | |||||
Capital Expenditures, 1 Yr. Growth % | 5.04 | -4.01 | -19.9 | -1.84 | -0.31 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -147.54 | 341.3 | -255.11 | -106.48 | -618.12 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -130.87 | 404.12 | -266.34 | -104.61 | -843.8 | |||||
Dividend Per Share, 1 Yr. Growth % | 5 | 0 | -90.48 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 5.4 | 15.11 | 4.9 | -11.28 | -8.08 | |||||
Gross Profit, 2 Yr. CAGR % | 2.33 | 11.57 | -8.81 | -18.14 | -5.56 | |||||
EBITDA, 2 Yr. CAGR % | -0.58 | 3.9 | -24.66 | -21.8 | -11.09 | |||||
EBITA, 2 Yr. CAGR % | -1.55 | 6.6 | -56.27 | -40.92 | -59.89 | |||||
EBIT, 2 Yr. CAGR % | -4.24 | -0.4 | -51.55 | -75.2 | 28.62 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -4.67 | -54.89 | 169.42 | -2.46 | -17.29 | |||||
Net Income, 2 Yr. CAGR % | 14.12 | -46.85 | 28.81 | -15.86 | 14.13 | |||||
Normalized Net Income, 2 Yr. CAGR % | -6.91 | -44.43 | 3.71 | -42.95 | -11.04 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -6.27 | -54.52 | 169.58 | -1.92 | -17.27 | |||||
Accounts Receivable, 2 Yr. CAGR % | 17.12 | 12.08 | -17.7 | -8.04 | -6.79 | |||||
Inventory, 2 Yr. CAGR % | 16.9 | 31.88 | -8.74 | -14.89 | -5.25 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.28 | 3.5 | -5.95 | -3.87 | -10.46 | |||||
Total Assets, 2 Yr. CAGR % | 9.98 | 12.71 | -4.19 | -7.24 | -10.46 | |||||
Tangible Book Value, 2 Yr. CAGR % | 16.83 | -10.58 | 17.75 | 35.23 | -11.18 | |||||
Common Equity, 2 Yr. CAGR % | 18.63 | 21.37 | 9.47 | 1.85 | -11.88 | |||||
Cash From Operations, 2 Yr. CAGR % | -20.44 | -47.87 | 43.49 | 78.74 | -41.27 | |||||
Capital Expenditures, 2 Yr. CAGR % | -2.9 | -5.53 | -12.31 | -11.33 | -1.08 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -10.82 | 80.61 | 161.26 | -68.29 | -42.05 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -31.26 | 65.97 | 189.14 | -72.29 | -41.41 | |||||
Dividend Per Share, 2 Yr. CAGR % | 5.13 | 2.47 | -69.14 | -69.14 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3.46 | 5.94 | 3.23 | 1.43 | -11.15 | |||||
Gross Profit, 3 Yr. CAGR % | 1.91 | 3.21 | -6.6 | -5.23 | -16.42 | |||||
EBITDA, 3 Yr. CAGR % | -0.77 | -3.28 | -19.06 | -11.04 | -26.96 | |||||
EBITA, 3 Yr. CAGR % | -2.14 | -4.76 | -42.97 | -25.92 | -70.22 | |||||
EBIT, 3 Yr. CAGR % | -4.33 | -10.73 | -40.26 | -59.45 | -28.98 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -8.08 | -8.44 | -2.52 | 14.91 | 46.02 | |||||
Net Income, 3 Yr. CAGR % | -14.75 | 6.84 | -20.6 | -12.81 | 32.15 | |||||
Normalized Net Income, 3 Yr. CAGR % | 11.22 | -10.96 | -34.42 | -27.56 | -10.01 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 6.9 | -9.62 | -1.77 | 15.13 | 46.37 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.97 | 6.13 | -0.79 | -9.64 | -12.3 | |||||
Inventory, 3 Yr. CAGR % | 6.63 | 15.91 | 8.32 | -6.19 | -13.11 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 6.56 | 1.13 | 1.85 | -6.07 | -7.53 | |||||
Total Assets, 3 Yr. CAGR % | 6.58 | 9.07 | 2.86 | -2.66 | -11.79 | |||||
Tangible Book Value, 3 Yr. CAGR % | 7.6 | 6 | 8.18 | 16.84 | 7.84 | |||||
Common Equity, 3 Yr. CAGR % | 10.55 | 18.32 | 14.47 | 6.88 | -7.54 | |||||
Cash From Operations, 3 Yr. CAGR % | -11.44 | -37.23 | 12.73 | 7.67 | 22.04 | |||||
Capital Expenditures, 3 Yr. CAGR % | -0.21 | -7.12 | -10.58 | -8.95 | -7.8 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -37.85 | 76.06 | 71.51 | -23.8 | -19.54 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -45.16 | 61.56 | 65.93 | -27.2 | -17.04 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.27 | 3.39 | -53.58 | -54.33 | -54.33 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.37 | 4.37 | -0.32 | -1.32 | -1.45 | |||||
Gross Profit, 5 Yr. CAGR % | 0.91 | 2.24 | -6.17 | -5.93 | -6.18 | |||||
EBITDA, 5 Yr. CAGR % | -0.59 | -1.02 | -15.17 | -11.23 | -15.96 | |||||
EBITA, 5 Yr. CAGR % | 2.72 | -2.31 | -32.87 | -21.41 | -50.46 | |||||
EBIT, 5 Yr. CAGR % | -0.16 | -6.83 | -31.95 | -46.61 | -18.82 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 2.35 | 25.26 | 24.46 | -6.09 | -8.72 | |||||
Net Income, 5 Yr. CAGR % | 6.82 | 23.5 | 0.55 | -2.89 | -8.2 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.83 | -2.72 | 0.47 | -25.6 | -25.91 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 3.87 | 53.35 | 36.29 | -6.62 | -8.29 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.27 | -5.16 | -3.68 | 0.24 | -3.24 | |||||
Inventory, 5 Yr. CAGR % | 2.7 | 2.07 | 0.19 | 2.44 | 2.68 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -3.91 | -8.3 | 1.41 | -0.9 | -3.27 | |||||
Total Assets, 5 Yr. CAGR % | 1.27 | 1.62 | 2.16 | 2.23 | -2.69 | |||||
Tangible Book Value, 5 Yr. CAGR % | -8.3 | 16.51 | 11.47 | 16.75 | -0.03 | |||||
Common Equity, 5 Yr. CAGR % | 8.04 | 14.09 | 10.12 | 11.43 | 3.09 | |||||
Cash From Operations, 5 Yr. CAGR % | -9.99 | -28.78 | 7.42 | -4.6 | -13.15 | |||||
Capital Expenditures, 5 Yr. CAGR % | 1.76 | 0.5 | -7.52 | -8.83 | -6.9 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -38.93 | -10.96 | 20.57 | -11.36 | 11.12 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -42.25 | -12.27 | 19.54 | -20.24 | 9.41 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.45 | 5.59 | -35.56 | -36.25 | -36.9 |
- Stock Market
- Equities
- LXS Stock
- Financials LANXESS AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















